Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes

OBJECTIVE: Methylglyoxal (MGO), a reactive aldehyde forming advanced glycation end products (AGEs), is increased in diabetes and recognized by the immune system, resulting in anti-AGE–specific autoantibodies. The association of these immune responses with macro- and microvascular complications in ty...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Care
Autors principals: Sveen, Kari Anne, Bech Holte, Kristine, Svanteson, Mona, Hanssen, Kristian F., Nilsson, Jan, Bengtsson, Eva, Julsrud Berg, Tore
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2021
Matèries:
Cardiovascular and Metabolic Risk
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247486/
https://ncbi.nlm.nih.gov/pubmed/33858856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-2089
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars